Project Details
Description
Phase I/II Study of Ixazomib and Romidepsin in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL): Big Ten Cancer Research Consortium BTCRC-HEM15-028
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/18 → 8/30/22 |
Funding
- BIG TEN CANCER RESEARCH CONSORTIUM
- TAKEDA DEVELOPMENT CENTER AMERICAS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.